BH3 Profiling Discriminates Response to Cytarabine-Based Treatment of Acute Myelogenous LeukemiaWilliam E. Pierceall, Michael Andreeff, Nicole E. Carlson et al.|Molecular Cancer Therapeutics|2013Cited by 32